Compare BRBS & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BRBS | TKNO |
|---|---|---|
| Founded | 1893 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.8M | 308.3M |
| IPO Year | 2015 | 2021 |
| Metric | BRBS | TKNO |
|---|---|---|
| Price | $3.46 | $5.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 363.4K | 137.9K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 24.78% | N/A |
| EPS Growth | ★ 135.48 | 43.86 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $111,284,000.00 | $40,520,000.00 |
| Revenue This Year | N/A | $8.27 |
| Revenue Next Year | N/A | $13.13 |
| P/E Ratio | $339.00 | ★ N/A |
| Revenue Growth | ★ 123.99 | 7.35 |
| 52 Week Low | $3.23 | $1.91 |
| 52 Week High | $4.79 | $6.68 |
| Indicator | BRBS | TKNO |
|---|---|---|
| Relative Strength Index (RSI) | 50.60 | 45.14 |
| Support Level | $3.41 | $5.00 |
| Resistance Level | $3.53 | $5.88 |
| Average True Range (ATR) | 0.07 | 0.38 |
| MACD | -0.01 | -0.08 |
| Stochastic Oscillator | 56.25 | 23.33 |
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, and others. It generates the majority of its revenue from commercial banking.
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.